Vizsgálati helyszín
Boston University Medical Center
Boston, Massachusetts 02118, Egyesült ÁllamokMég nincs intézményhez kötve
- 12futó vizsgálat
- 9lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 21 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis7 vizsgálat
- 2. fázis4 vizsgálat
- 4. fázis2 vizsgálat
- 1. fázis1 vizsgálat
- 1/2. fázis1 vizsgálat
- Állapot
- Fut, nem toboroz8 vizsgálat
- Lezárult6 vizsgálat
- Toboroz3 vizsgálat
- Leállították3 vizsgálat
- Meghívásos bevonás1 vizsgálat
- Fő szponzor
- Janssen Research & Development, LLC8 vizsgálat
- United Therapeutics2 vizsgálat
- Biogen1 vizsgálat
- Boston University1 vizsgálat
- CHDI Foundation, Inc.1 vizsgálat
- és még 8
Futó vizsgálatok
Toboroz
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
NCT07258511· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation
NCT05723926· Javelin Medical· Forrás
Contact: Thanh Nguyen, Dr
Toboroz
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
NCT06667076· 2. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis
NCT06097832· 1/2. fázis· Nexcella Inc.· Forrás
Fut, nem toboroz
A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma
NCT05572515· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment
NCT05455320· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
NCT06426628· Veracyte, Inc.· Forrás
Contact: Ehab Billatos, MD
Fut, nem toboroz
A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis
NCT05250973· 2. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab
NCT04270175· 2. fázis· Weill Medical College of Cornell University· Forrás
Meghívásos bevonás
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186· 3. fázis· United Therapeutics· Forrás
Fut, nem toboroz
A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer
NCT04077463· 1. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer
NCT02504697· Boston University· Forrás
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Lezárt vizsgálatok
Lezárult
A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80
NCT05348785· 2. fázis· Biogen· Forrás
Leállították
Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD
NCT04930445· Pfizer· Forrás
Toboroz
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
NCT04373564· 4. fázis· Guerbet· Forrás
Contact: Nathalie LE FUR, PhD
Lezárult
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
NCT03626688· 3. fázis· United Therapeutics· Forrás
Lezárult
A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy
NCT03652064· 3. fázis· Janssen Research & Development, LLC· Forrás
Lezárult
PRO-ACTIVE: Prophylactic Swallow Intervention for Patients Receiving Radiotherapy for Head and Neck Cancer
NCT03455608· University Health Network, Toronto· Forrás
Lezárult
A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis
NCT03201965· 3. fázis· Janssen Research & Development, LLC· Forrás
Lezárult
Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement
NCT02810704· 4. fázis· Dartmouth-Hitchcock Medical Center· Forrás
Toboroz
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
NCT01574053· CHDI Foundation, Inc.· Forrás
Contact: Noopur Modi
Hibát jelzek